What are the details of Actelion’s IPO?
The registered shares of Actelion Ltd were first listed on the Swiss Stock Exchange (SIX) New Market on 6 April 2000 (symbol: ATLN). A total of 1,000,000 primary shares were placed at the company’s Initial Public Offering (IPO), at a price of CHF 260 per share (a price of 13 CHF after two stock splits which occurred in 2001 and 2007). Actelion’s IPO was effected through an international banking syndicate led by Credit Suisse First Boston, and constituted one of the largest ever to take place for a biopharmaceutical company, raising CHF 246.6 million.
